Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Mar 2021 for Neos Therapeutics, Inc..
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gregory J. Robitaille: trading record in brief
Gregory J. Robitaille is a declared insider of Neos Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 18 May 2016 and the latest from 19 March 2021.
The open-market record is one-sided, with 1 purchase worth €50k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant.
Most recently, on 19 March 2021, the filings show a transaction in Neos Therapeutics, Inc. The latest purchase dates back some time: it was published 3,809 days ago, on 19 May 2016. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gregory J. Robitaille
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
79,130 sharesCommon StockSEC:0001104659-21-039210:0
23,453 shares0Common StockSEC:0001104659-20-072550:0
7,442 shares@ US$7.55100.0% of flowCommon StockSEC:0001179110-16-025080:0
Canonical exit: 16 Aug 2016 (T+90)
3 of 3 declarations
